-
1 Comment
Rohto Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 4.8% below its 200 day moving average.
From a valuation standpoint, the stock is 80.9% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 1.9.
Rohto Pharmaceutical Co., Ltd's total revenue sank by 2.1% to $47B since the same quarter in the previous year.
Its net income has dropped by 6.7% to $5B since the same quarter in the previous year.
Based on the above factors, Rohto Pharmaceutical Co., Ltd gets an overall score of 0/5.
ISIN | JP3982400008 |
---|---|
Sector | Consumer Defensive |
Industry | Household & Personal Products |
Exchange | TSE |
CurrencyCode | JPY |
Market Cap | 533B |
---|---|
Target Price | 2966.25 |
Dividend Yield | 1.5% |
Beta | -0.35 |
PE Ratio | 18.24 |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4527.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025